Literature DB >> 12574508

The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase.

Annette Cronin1, Sherry Mowbray, Heike Dürk, Shirli Homburg, Ingrid Fleming, Beate Fisslthaler, Franz Oesch, Michael Arand.   

Abstract

The mammalian soluble epoxide hydrolase (sEH) is an enzyme with multiple functions, being implicated in detoxification of xenobiotic epoxides as well as in regulation of physiological processes such as blood pressure. The enzyme is a homodimer, in which each subunit is composed of two domains. The 35-kDa C-terminal domain has an alpha/beta hydrolase fold and harbors the catalytic center for the EH activity. The 25-kDa N-terminal domain has a different alpha/beta fold and belongs to the haloacid dehalogenase superfamily of enzymes. The catalytic properties of the enzyme reported so far can all be explained by the action of the C-terminal domain alone. The function of the N-terminal domain, other than in structural stabilization of the dimer, has therefore remained unclear. By structural comparison of this domain to other haloacid dehalogenase family members, we identified a putative active site containing all necessary components for phosphatase activity. Subsequently, we found rat sEH hydrolyzed 4-nitrophenyl phosphate with a rate constant of 0.8 s(-1) and a K(m) of 0.24 mM. Recombinant human sEH lacking the C-terminal domain also displayed phosphatase activity. Presence of a phosphatase substrate did not affect epoxide turnover nor did epoxides affect dephosphorylation by the intact enzyme, indicating both catalytic sites act independently. The enzyme was unable to hydrolyze 4-nitrophenyl sulfate, suggesting its role in xenobiotic metabolism does not extend beyond phosphates. Thus, we propose this domain participates instead in the regulation of the physiological functions associated with sEH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574508      PMCID: PMC149870          DOI: 10.1073/pnas.0437829100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase.

Authors:  M A Argiriadi; C Morisseau; B D Hammock; D W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Detecting protein function and protein-protein interactions from genome sequences.

Authors:  E M Marcotte; M Pellegrini; H L Ng; D W Rice; T O Yeates; D Eisenberg
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

3.  Protein folds and families: sequence and structure alignments.

Authors:  L Holm; C Sander
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

4.  Hidden Markov models for detecting remote protein homologies.

Authors:  K Karplus; C Barrett; R Hughey
Journal:  Bioinformatics       Date:  1998       Impact factor: 6.937

Review 5.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

Review 6.  Sulfation and sulfotransferases 4: bioactivation of mutagens via sulfation.

Authors:  H Glatt
Journal:  FASEB J       Date:  1997-04       Impact factor: 5.191

7.  Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates.

Authors:  F Müller; M Arand; H Frank; A Seidel; W Hinz; L Winkler; K Hänel; E Blée; J K Beetham; B D Hammock; F Oesch
Journal:  Eur J Biochem       Date:  1997-04-15

8.  Three-dimensional structure of L-2-haloacid dehalogenase from Xanthobacter autotrophicus GJ10 complexed with the substrate-analogue formate.

Authors:  I S Ridder; H J Rozeboom; K H Kalk; D B Janssen; B W Dijkstra
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

9.  Crystal structure of L-2-haloacid dehalogenase from Pseudomonas sp. YL. An alpha/beta hydrolase structure that is different from the alpha/beta hydrolase fold.

Authors:  T Hisano; Y Hata; T Fujii; J Q Liu; T Kurihara; N Esaki; K Soda
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

10.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation.

Authors:  S Dimmeler; I Fleming; B Fisslthaler; C Hermann; R Busse; A M Zeiher
Journal:  Nature       Date:  1999-06-10       Impact factor: 49.962

View more
  53 in total

1.  Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols.

Authors:  Timo Frömel; Benno Jungblut; Jiong Hu; Caroline Trouvain; Eduardo Barbosa-Sicard; Rüdiger Popp; Stefan Liebner; Stefanie Dimmeler; Bruce D Hammock; Ingrid Fleming
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase.

Authors:  Hsin-Han Hou; Bruce D Hammock; Kou-Hui Su; Christophe Morisseau; Yu Ru Kou; Susumu Imaoka; Ami Oguro; Song-Kun Shyue; Jin-Feng Zhao; Tzong-Shyuan Lee
Journal:  Cardiovasc Res       Date:  2011-11-08       Impact factor: 10.787

3.  The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.

Authors:  Myriam Fornage; Craig R Lee; Peter A Doris; Molly S Bray; Gerardo Heiss; Darryl C Zeldin; Eric Boerwinkle
Journal:  Hum Mol Genet       Date:  2005-08-22       Impact factor: 6.150

4.  TPPU protects tau from H2O2-induced hyperphosphorylation in HEK293/tau cells by regulating PI3K/AKT/GSK-3β pathway.

Authors:  En-Sheng Yao; Yan Tang; Xing-Hua Liu; Ming-Huan Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

Review 5.  Soluble epoxide hydrolase inhibitors and heart failure.

Authors:  Hong Qiu; Ning Li; Jun-Yan Liu; Todd R Harris; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Cardiovasc Ther       Date:  2011-04       Impact factor: 3.023

6.  Proton shuttles and phosphatase activity in soluble epoxide hydrolase.

Authors:  Marco De Vivo; Bernd Ensing; Matteo Dal Peraro; German A Gomez; David W Christianson; Michael L Klein
Journal:  J Am Chem Soc       Date:  2007-01-17       Impact factor: 15.419

Review 7.  Mechanisms for incorporation of glycerol-derived precursors into polyketide metabolites.

Authors:  Laura J Walton; Christophe Corre; Gregory L Challis
Journal:  J Ind Microbiol Biotechnol       Date:  2005-09-27       Impact factor: 3.346

Review 8.  Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.

Authors:  Arthur A Spector; Hee-Yong Kim
Journal:  Biochim Biophys Acta       Date:  2014-08-02

Review 9.  The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.

Authors:  Sean D Kodani; Bruce D Hammock
Journal:  Drug Metab Dispos       Date:  2015-03-11       Impact factor: 3.922

10.  Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia.

Authors:  Ines P Koerner; Wenri Zhang; Jian Cheng; Susan Parker; Patricia D Hurn; Nabil J Alkayed
Journal:  Front Biosci       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.